New Delhi: The Union Ministry of Health and Family Welfare has significantly expanded the nation’s pharmaceutical track-and-trace mechanism by making barcodes or Quick Response (QR) codes compulsory for all vaccines, antimicrobials, anti-cancer medicines, and narcotic and psychotropic drugs. The landmark regulatory update, issued via an official gazette notification on Thursday, marks a major step forward by the central government to eliminate counterfeit, spurious, and substandard medicines from the country’s domestic healthcare supply chain.
By executing comprehensive amendments to the Drugs Rules, 1945, the health ministry has officially brought these vital and high-risk therapeutic categories under the legislative purview of Schedule H2. Previously, the mandate for QR code-based digital authentication was restricted exclusively to the country’s top 300 selling pharmaceutical brands. Under the newly modified legal framework, all manufacturers operating within these sectors are strictly required to print or affix an algorithmic barcode or QR code directly onto the primary product packaging label, with the provision that it can be placed on the secondary outer packaging only if severe space constraints exist on individual vials or strips.
The embedded tracking codes are systematically structured to store critical manufacturing data that can be seamlessly scanned and read via software applications by distributors, retailers, and public consumers to verify authenticity. The encoded information will feature a unique product identification code, precise generic and brand names, the complete name and corporate address of the manufacturing entity, batch numbers, exact manufacturing and expiry dates, the official manufacturing licence number, and comprehensive data regarding active excipients wherever applicable. Beyond halting the distribution of fake life-saving drugs, health officials emphasized that tracking all antimicrobials will serve as a vital defensive weapon in India’s ongoing battle against Anti-Microbial Resistance (AMR) by effectively mapping out the supply chain of authentic antibiotics.
Recognising the massive technical and infrastructural overhauls required by the domestic pharmaceutical industry to upgrade high-speed packaging lines, the ministry has outlined a staggered, multi-year timeline for mandatory compliance. The strict labeling and tracking provisions governing all vaccines, anti-cancer medications, and narcotic or psychotropic substances regulated under the NDPS Act, 1985, are scheduled to come into effect starting July 1, 2027. Meanwhile, the stringent regulatory mandate for all categories of antimicrobials will become legally binding exactly one year later, effective from July 1, 2028.
